The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Molecular basis for catecholaminergic neuron diversity
Open accessAbstract
Catecholaminergic neurons control diverse cognitive, motor, and endocrine functions and are associated with multiple psychiatric and neurodegenerative disorders. We present global gene-expression profiles that define the four major classes of dopaminergic (DA) and noradrenergic neurons in the brain. Hypothalamic DA neurons and noradrenergic neurons in the locus coeruleus display distinct group-specific signatures of transporters, channels, transcription, plasticity, axon-guidance, and survival factors. In contrast, the transcriptomes of midbrain DA neurons of the substantia nigra and the ventral tegmental area are closely related with <1% of differentially expressed genes. Transcripts implicated in neural plasticity and survival are enriched in ventral tegmental area neurons, consistent with their role in schizophrenia and addiction and their decreased vulnerability in Parkinson's disease. The molecular profiles presented provide a basis for understanding the common and population-specific properties of catecholaminergic neurons and will facilitate the development of selective drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bulk profiling experiments comparing SNc and VTA neurons did indeed yield some interesting gene expression differences [6–9], but suffered from the caveat that they could not distinguish heterogeneous populations within each anatomical cluster.”
From Classification of midbrain dopamine neurons using single-cell gene expression profiling approaches (2020) · cites this paper as [6]
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F. Z., Miled, S. B., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,785
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Dahlstroem, A., & Fuxé, K. (1964) · PubMed · Cited by 5,133
Handbook of Chemical Neuroanatomy
Stern, C. D. (1986) · Neurochemistry International · doi:10.1016/0197-0186(86)90021-5 · Cited by 4,160
The Neuroendocrinology of Stress: A Never Ending Story
Lightman, S. L. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01711.x · Cited by 3,588
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,674
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
Hirsch, E., Graybiel, A. M., & Agid, Y. A. (1988) · Nature · doi:10.1038/334345a0 · Cited by 1,301
Amplified RNA synthesized from limited quantities of heterogeneous cDNA.
Gelder, R. N. V., von Zastrow, M., Yool, A., Dement, W. C., Barchas, J. D., & Eberwine, J. H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1663 · Cited by 1,252
Kimura, S., Hara, Y., Pineau, T., Fernández‐Salguero, P. M., Fox, C. H., Ward, J. M., & Gonzalez, F. J. (1996) · Genes & Development · doi:10.1101/gad.10.1.60 · Cited by 1,221
Schizophrenia as a Disorder of Neurodevelopment
Lewis, D. A., & Levitt, P. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142754 · Cited by 1,163
Description of Parkinson's Disease as a Clinical Syndrome
Fahn, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07458.x · Cited by 979
The Neurobiology of Sleep: Genetics, cellular physiology and subcortical networks
Pace-Schott, E. F., & Hobson, J. A. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn895 · Cited by 937
FGF and Shh Signals Control Dopaminergic and Serotonergic Cell Fate in the Anterior Neural Plate
Ye, W., Shimamura, K., Rubenstein, J. L. R., Hynes, M., & Rosenthal, A. (1998) · Cell · doi:10.1016/s0092-8674(00)81437-3 · Cited by 878
Kitamura, K., Yanazawa, M., Sugiyama, N., Miura, H., Iizuka‐Kogo, A., Kusaka, M., Omichi, K., Suzuki, R., Fukui, Y., Kamiirisa, K., et al. (2002) · Nature Genetics · doi:10.1038/ng1009 · Cited by 726
Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia
Meyer-Lindenberg, A., Miletich, R. S., Kohn, P. D., Esposito, G., Carson, R. E., Quarantelli, M., Weinberger, D. R., & Berman, K. F. (2002) · Nature Neuroscience · doi:10.1038/nn804 · Cited by 652
It could be habit forming: drugs of abuse and striatal synaptic plasticity
Gerdeman, G. L., Partridge, J. G., Lupica, C. R., & Lovinger, D. M. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00065-1 · Cited by 480
Motor Neuron–Derived Retinoid Signaling Specifies the Subtype Identity of Spinal Motor Neurons
Sockanathan, S., & Jessell, T. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81591-3 · Cited by 388
Yamagata, M., Sanes, J. R., & Weiner, J. A. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00107-8 · Cited by 374
Synaptopodin-deficient mice lack a spine apparatus and show deficits in synaptic plasticity
Deller, T., Körte, M., Chabanis, S., Drakew, A., Schwegler, H., Stefani, G. G., Zúñiga, A., Schwarz, K., Bonhoeffer, T., Zeller, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1832384100 · Cited by 291
Uhl, G. R., Hedreen, J. C., & Price, D. L. (1985) · Neurology · doi:10.1212/wnl.35.8.1215 · Cited by 242
PACAP protects cerebellar granule neurons against oxidative stress‐induced apoptosis
Vaudry, D., Pamantung, T. F., Basille, M., Cottet‐Rousselle, C., Fournier, A., Vaudry, H., Beauvillain, J., & Gonzalez, B. J. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01981.x · Cited by 188
Fiscus, R. R. (2002) · Neurosignals · doi:10.1159/000065431 · Cited by 187
Kaul, S., Kanthasamy, A., Kitazawa, M., Anantharam, V., & Kanthasamy, A. G. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02864.x · Cited by 165
Kitazawa, M., Anantharam, V., & Kanthasamy, A. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00226-4 · Cited by 163
The dopamine-containing neuron: maestro or simple musician in the orchestra of addiction?
Bonci, A., Bernardi, G., Grillner, P., & Mercuri, N. B. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00068-3 · Cited by 160
Hyperprolactinemia: Etiology, Diagnosis, and Management
Mah, P. M., & Webster, J. A. (2002) · Seminars in Reproductive Medicine · doi:10.1055/s-2002-36709 · Cited by 153
Yue, Y., Widmer, D. A. J., Halladay, A. K., Cerretti, D. P., Wagner, G. C., Dreyer, J., & Zhou, R. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-06-02090.1999 · Cited by 133
Varastet, M., RICHE, D., Mazière, M., & Hantraye, P. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90006-x · Cited by 118
Preservation of hypothalamic dopaminergic neurons in Parkinson's disease
Matzuk, M. M., & Saper, C. B. (1985) · Annals of Neurology · doi:10.1002/ana.410180507 · Cited by 113
Holzschuh, J., Barrallo‐Gimeno, A., Ettl, A.-K., Dürr, K., Knapik, E. W., & Driever, W. (2003) · Development · doi:10.1242/dev.00816 · Cited by 110
Thomas, K. L., Arroyo, M., & Everitt, B. J. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02617.x · Cited by 107
Delayed Mesolimbic System Alteration in a Developmental Animal Model of Schizophrenia
Goto, Y., & O’Donnell, P. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-20-09070.2002 · Cited by 92
Viggiano, D., Vallone, D., Ruocco, L. A., & Sadile, A. G. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.08.011 · Cited by 88
Kim, H., Hong, S. J., LeDoux, M. S., & Kim, K. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00044.x · Cited by 80
The coupling of a trkB tyrosine residue to LTP
Ernfors, P., & Bramham, C. R. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00064-x · Cited by 78
Zinc-induced apoptosis in substantia nigra of rat brain: neuroprotection by vitamin D3
Lin, A. M., Fan, S., Yang, D., Hsu, L. L., & Yang, J. C. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00105-9 · Cited by 78
Dlx transcription factors regulate differentiation of dopaminergic neurons of the ventral thalamus
Andrews, G. L., Yun, K., Rubenstein, J. L. R., & Mastick, G. S. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00016-2 · Cited by 74
Purba, J. S., Hofman, M. A., & Swaab, D. F. (1994) · Neurology · doi:10.1212/wnl.44.1.84 · Cited by 72
Sheng, H., Kudo, M., Mackensen, G. B., Pearlstein, R. D., Crapo, J. D., & Warner, D. S. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7363 · Cited by 67
Bolaños, C. A., Perrotti, L. I., Edwards, S., Eisch, A. J., Barrot, M., Olson, V. G., Russell, D. S., Neve, R. L., & Nestler, E. J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-20-07569.2003 · Cited by 62
Monoaminergic synapses and schizophrenia: 45 years of neuroleptics
Bennett, M. R. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200310 · Cited by 50
Zuddas, A., Corsini, G. U., Schinelli, S., Johannessen, J. N., di Porzio, U., & Kopin, I. J. (1989) · Brain Research · doi:10.1016/0006-8993(89)91020-2 · Cited by 49
Mesolimbic dopaminergic neurons are not spared by MPTP neurotoxicity in mice
Melamed, E., Rosenthal, J., Globus, M., Cohen, O. S., Frucht, Y., & Uzzan, A. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90528-x · Cited by 41
Paradis, E., Clément, S., Julien, P., & Murthy, M. R. V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208452200 · Cited by 39
Mutschler, N. H., Miczek, K. A., & Hammer, R. P. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00298-0 · Cited by 39
Evidence for the pro-oxidant effect of γ-glutamyltranspeptidase–related enzyme
Enoiu, M., Aberkane, H., Salazar, J.-F., Leroy, P., Groffen, J., Siest, G., & Wellman, M. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00370-1 · Cited by 36
Maturation-dependent apoptotic cell death of oligodendrocytes in myelin-deficient rats
Grinspan, J. B., Coulalaglou, M., Beesley, J., Carpio, D. F., & Scherer, S. S. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981201)54:5 · Cited by 33
Espejo, M., Cutillas, B., Ventura, F., & Ambrosio, S. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00708-9 · Cited by 27
Mogi, M., Harada, M., Kojima, K., Kiuchi, K., & Nagatsu, T. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb10572.x · Cited by 27
Bruyninx, M., Hennuy, B., Cornet, A. M., Houssa, P., Daukandt, M., Reiter, É., Poncin, J., Closset, J., & Hennen, G. P. (1999) · Endocrinology · doi:10.1210/endo.140.10.7097 · Cited by 24
Flagged first, then by citations
Research works printed but not linked: 2
- Dahlstroem, A. & Fuxe, K. (1964) Acta Physiol. Scand. Suppl. 232, 1–55.
- Holzschuh, J., Barrallo-Gimeno, A., Ettl, A. K., Durr, K., Knapik, E. W. & Driever, W. (2003) Development (Cambridge, U.K.) 130, 5741–5754.
Cited by
Sorted by citations
The SH-SY5Y cell line in Parkinson’s disease research: a systematic review
Xicoy, H., Wieringa, B., & Martens, G. J. M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0149-0 · Cited by 1,036
The reticular-activating hypofrontality (RAH) model of acute exercise
Dietrich, A., & Audiffren, M. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.02.001 · Cited by 365
Dissecting the diversity of midbrain dopamine neurons
Roeper, J. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.03.003 · Cited by 395
Chung, C. Y., Seo, H., Sonntag, K. C., Brooks, A., Lin, L., & Isacson, O. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi178 · Cited by 361
Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling
Poulin, J.-F., Zou, J., Drouin-Ouellet, J., Kim, K.-Y. A., Cicchetti, F., & Awatramani, R. B. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.008 · Cited by 352
Metadata
- Authors
- Grimm, J., Mueller, A., Hefti, F., & Rosenthal, A.
- Affiliations
- Stanford Medicine (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-09-07
- Volume
- 101
- Issue
- 38
- Pages
- 13891-13896
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC518849
- OpenAlex
- W2131058184
- Cited by
- 150
- References
- 55
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 6 · 2023: 15 · 2022: 5 · 2021: 3 · 2020: 4 · 2019: 7 · 2018: 4 · 2017: 10 · 2016: 10 · 2015: 8 · 2014: 14 · 2013: 8 · 2012: 7
- FWCI
- 2.93
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- catecholaminergic neurons, dopaminergic neurons, noradrenergic neurons, neuronal heterogeneity, gene expression profiling, locus coeruleus, substantia nigra, ventral tegmental area, midbrain dopaminergic neurons, neuroplasticity, axon guidance, schizophrenia, addiction, Parkinson's disease
- MeSH terms
- Animals, Catecholamines, Female, Gene Amplification, Hydrogen Peroxide, Neurons, RNA, Rats, Sprague-Dawley, In Situ Hybridization, Pyramidal Cells, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review